Earmark - Chemical-Biological Casualty Treatment (Note: transferred from RDTE,A line 154)

Agency:		Department of Defense--Military
Bureau:		Research, Development, Test, and Evaluation
Account:		Research, development, test, and evaluation, Army (21-2040)
Certifying Official:		Deputy Comptroller Program/Budget
Contact Information:		http://WWW.DOD.GOV 703-697-5131

Chemical-Biological Casualty Treatment (Note: transferred from RDTE,A line 154)

1 recipient will receive $2,396,000. This is a continuing earmark.

Year Enacted: 2005

Description: This proposal objective will focus on the need to effect changes in our medication management process that could yield notable improvements in patient safety, clinical effectiveness, and efficiency. Holy Name Hospital has a medication management redesign that describes a strategy for incorporation and integrating technology that attempts to close the loop for error reduction, ADE (adverse drug events) detection, and integrated data collection in a manner that is unique according to feedback from vendors and literature.

Beneficiary/Recipient	Amount ($K)	Program	Type	Address
Holy Name Hospital	$2,396		For-Profit	Teaneck, NJ

Citation

Source: Appropriations Report Language - Conference

Reference: 108-622

Location: Line 117, Page 267

Citation Excerpt: Chemical-Biological Casualty Treatment (Note: transferred from RDTE,A line 154)

Last Modified: 16-Apr-2007